Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy.
de Boer MJ, Ottervanger JP, van 't Hof AW, Hoorntje JC, Suryapranata H, Zijlstra F; Zwolle Myocardial Infarction Study Group. de Boer MJ, et al. Among authors: ottervanger jp. J Am Coll Cardiol. 2002 Jun 5;39(11):1723-8. doi: 10.1016/s0735-1097(02)01878-8. J Am Coll Cardiol. 2002. PMID: 12039482 Free article. Clinical Trial.
Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failure.
De Luca G, van 't Hof AW, de Boer MJ, Hoorntje JC, Gosselink AT, Dambrink JH, Ottervanger JP, Zijlstra F, Suryapranata H. De Luca G, et al. Among authors: ottervanger jp. Circulation. 2004 Mar 2;109(8):958-61. doi: 10.1161/01.CIR.0000120504.31457.28. Epub 2004 Feb 23. Circulation. 2004. PMID: 14981008
Angiographic predictors of left ventricular ejection fraction after successful angioplasty in acute myocardial infarction: an angiographic risk score for use in the catheterization laboratory.
Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, Dambrink JH, Gosselink AT, van 't Hof AW, Hoorntje JC, Suryapranata H. Henriques JP, et al. Among authors: ottervanger jp. Catheter Cardiovasc Interv. 2004 Mar;61(3):338-43. doi: 10.1002/ccd.10781. Catheter Cardiovasc Interv. 2004. PMID: 14988892
Long-term, cause-specific mortality after myocardial infarction in diabetes.
Timmer JR, Ottervanger JP, Thomas K, Hoorntje JC, de Boer MJ, Suryapranata H, Zijlstra F; Zwolle Myocardial Infarction Study Group. Timmer JR, et al. Among authors: ottervanger jp. Eur Heart J. 2004 Jun;25(11):926-31. doi: 10.1016/j.ehj.2004.04.001. Eur Heart J. 2004. PMID: 15172464 Clinical Trial.
Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Ernst NM, Suryapranata H, Miedema K, Slingerland RJ, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, de Boer MJ, Zijlstra F, van 't Hof AW. Ernst NM, et al. Among authors: ottervanger jp. J Am Coll Cardiol. 2004 Sep 15;44(6):1187-93. doi: 10.1016/j.jacc.2004.06.050. J Am Coll Cardiol. 2004. PMID: 15364318 Free article. Clinical Trial.
326 results